Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Bosulif

(BAH-soo-lif)
A drug used to treat adults and children aged 1 year and older with chronic myelogenous leukemia that is Philadelphia chromosome positive. It is used in some newly diagnosed patients. It is also used in patients who cannot be treated with or have not gotten better after other treatment. It is also being studied in the treatment of other types of cancer. Bosulif blocks BCR::ABL1 and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called bosutinib.
More Information
Search NCI's Dictionary of Cancer Terms